Valuation: AstraZeneca PLC

Market Cap 258B 226B 209B 192B 362B 24,850B 368B 2,496B 979B 12,159B 968B 947B 41,890B P/E 2026 *
20.8x
P/E 2027 * 18.2x
Enterprise Value 277B 243B 224B 206B 389B 26,701B 396B 2,682B 1,052B 13,064B 1,040B 1,017B 45,010B EV / Sales 2026 *
4.38x
EV / Sales 2027 * 4.04x
Free-Float
96.63%
Yield 2026 *
2.01%
Yield 2027 * 2.12%

Last Transcript: AstraZeneca PLC

1 day-1.70%
1 week-1.82%
Current month-12.20%
1 month-6.45%
3 months-17.20%
6 months-8.43%
Current year-10.22%
1 week 11,870
Extreme 11870
12,672
1 month 11,870
Extreme 11870
14,686
Current year 11,232
Extreme 11232
15,732
1 year 10,198
Extreme 10198
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Free

See Remarks

2 0.0000%
6/8/26 Free

See Remarks

1 0.0000%
5/20/26 Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-1.70%-1.82%+20.26%+15.74% 258B
-2.73%-2.96%+48.62%+147.27% 1,023B
-1.67%-3.47%+52.00%+47.77% 599B
-0.44%+2.17%+33.88%+78.20% 448B
-0.75%+0.30%+28.32%+21.15% 326B
-1.52%-1.19%+33.38%+35.35% 278B
-0.58%+1.11%-20.89%-40.59% 222B
-0.58%+1.03%+23.55%+56.14% 197B
-0.80%+1.38%+23.09%+66.64% 165B
-1.20%+1.10%+1.14%-32.69% 141B
Average -0.80%-0.24%+24.34%+39.50% 365.61B
Weighted average by Cap. -0.90%-1.10%+33.85%+66.60%

Financials

2026 *2027 *
Net sales 63.21B 55.41B 51.21B 47.1B 88.87B 6,096B 90.3B 612B 240B 2,983B 237B 232B 10,276B 66.79B 58.54B 54.11B 49.77B 93.9B 6,440B 95.41B 647B 254B 3,151B 251B 245B 10,857B
Net income 12.43B 10.9B 10.07B 9.26B 17.48B 1,199B 17.76B 120B 47.21B 587B 46.68B 45.66B 2,021B 13.94B 12.22B 11.29B 10.38B 19.59B 1,344B 19.91B 135B 52.93B 658B 52.33B 51.19B 2,266B
Net Debt 19.2B 16.82B 15.55B 14.3B 26.99B 1,851B 27.42B 186B 72.9B 906B 72.08B 70.51B 3,120B 11.9B 10.43B 9.64B 8.87B 16.73B 1,148B 17B 115B 45.2B 562B 44.69B 43.72B 1,935B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-20 GBX 12,380.00 -1.70% 1,718,968
26-07-17 GBX 12,594.00 -0.27% 2,012,949
26-07-16 GBX 12,628.00 +0.49% 1,602,666
26-07-15 GBX 12,566.00 +1.63% 3,346,169
26-07-14 GBX 12,364.00 -1.95% 3,313,274
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
166.14USD
Average target price
212.13USD
Spread / Average Target
+27.68%

Quarterly revenue - Rate of surprise